RxSight Price to Sales Ratio 2021-2024 | RXST
Historical PS ratio values for RxSight (RXST) over the last 10 years. The current P/S ratio for RxSight as of May 02, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| RxSight P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-05-02 | 15.85 | 4.37 | |
| 2024-12-31 | 34.38 | $3.63 | 9.47 |
| 2024-09-30 | 49.43 | $3.43 | 14.43 |
| 2024-06-30 | 60.17 | $3.16 | 19.04 |
| 2024-03-31 | 51.58 | $2.86 | 18.06 |
| 2023-12-31 | 40.32 | $2.61 | 15.46 |
| 2023-09-30 | 27.89 | $2.36 | 11.82 |
| 2023-06-30 | 28.80 | $2.19 | 13.13 |
| 2023-03-31 | 16.68 | $2.00 | 8.33 |
| 2022-12-31 | 12.67 | $1.78 | 7.13 |
| 2022-09-30 | 12.00 | $1.81 | 6.62 |
| 2022-06-30 | 14.08 | $1.67 | 8.45 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.608B | $0.140B |
| RxSight Inc. is a commercial-stage medical technology company focuses on patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens(R), RxSight Light Delivery Device and accessories. RxSight Inc. is based in ALISO VIEJO, Calif. | |||